Aldometanib

Overview

Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib can activate lysosomal adenosine monophosphate-activated protein kinase ( AMPK ) and decreases blood glucose. Aldometanib can be used for the research of metabolic homeostasis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Fructose-1,6-bisphosphate aldolase | Products > Signaling Pathways > AMPK

Product Information

• Catalog No.: HY-148189
• CAS No.: 2904601-67-6
• Molecular Formula: C27H43Cl2IN2
• Molecular Weight: 593.45
• Purity: 99.65%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (4.21 mM); Clear solution
• Availability: In-stock

Source

Original product source